Trial report in Viruses, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
4 citing papers in PubMed, 5 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
13 authors at 7 institutions in 4 countries.
Emma Pujol-HodgeAshworth Laboratories, School of Biological Sciences, University of Edinburgh, Edinburgh EH9 3FL, UK.ORCID 0000-0001-8861-6608
Jesus F Salazar-GonzalezMedical Research Council (MRC)/Uganda Virus Research Institute (UVRI) and London School of Hygiene and Tropical Medicine (LSHTM) Uganda Research Unit, Entebbe P.O. Box 49, Uganda.ORCID 0000-0003-4626-6448
Deogratius SsemwangaMedical Research Council (MRC)/Uganda Virus Research Institute (UVRI) and London School of Hygiene and Tropical Medicine (LSHTM) Uganda Research Unit, Entebbe P.O. Box 49, Uganda.ORCID 0000-0001-9675-4234
Edwin D CharleboisDivision of Prevention Science, Department of Medicine, University of California, San Francisco, CA 94158, USA.ORCID 0000-0001-7237-2119
James AyiekoKenya Medical Research Institute, Nairobi P.O. Box 54840-00200, Kenya.
Heather E GrantAshworth Laboratories, School of Biological Sciences, University of Edinburgh, Edinburgh EH9 3FL, UK.ORCID 0000-0001-9500-1644
Teri LieglerDivision of HIV, Infectious Diseases and Global Medicine, Department of Medicine, University of California, San Francisco, CA 94110, USA.
Katherine E AtkinsUsher Institute, University of Edinburgh, Edinburgh EH8 9AG, UK.ORCID 0000-0001-5250-0558
Pontiano KaleebuMedical Research Council (MRC)/Uganda Virus Research Institute (UVRI) and London School of Hygiene and Tropical Medicine (LSHTM) Uganda Research Unit, Entebbe P.O. Box 49, Uganda.
Moses R KamyaSchool of Medicine, Makerere University, Kampala P.O. Box 7072, Uganda.ORCID 0000-0001-9106-4234
Maya PetersenDivision of Biostatistics, School of Public Health, University of California, Berkeley, CA 94720, USA.
Diane V HavlirDivision of HIV, Infectious Diseases and Global Medicine, Department of Medicine, University of California, San Francisco, CA 94110, USA.
Andrew J Leigh BrownAshworth Laboratories, School of Biological Sciences, University of Edinburgh, Edinburgh EH9 3FL, UK.
Uganda Virus Research Institute · UGUniversity of California, San Francisco · USUniversity of Edinburgh · GBKenya Medical Research Institute · KELondon School of Hygiene & Tropical Medicine · GBMakerere University · UGUniversity of California, Berkeley · US
Funding
Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/UM1AI068636 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Joseph J Eron, RAJESH T GANDHI · 2011 to 2026
$1073.1M
Ujima Mentoring ProgramP30MH062246 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MALLORY O JOHNSON · 2001 to 2026
$57.4M
Reducing Failure-to-Initiate ART: Streamlined ART Start Strategy (START)U01AI099959 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HAVLIR, DIANE V · 2012 to 2016
$39.7M
Targeted Learning using adaptive designs for HIV Epidemic control in East AfricaR01AI074345 · NIAID · UNIVERSITY OF CALIFORNIA BERKELEY · PI PETERSEN, MAYA LIV, VANDERLAAN, MARK J · 2007 to 2023
$6.6M
Modeling Epidemic Infectious Diseases Using Sequence AnalysisU01GM110749 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI POND, SERGEI L KOSAKOVSKY · 2014 to 2018
$3.0M
European Research Council Starting Grant 757688Medical Research Council MC_UU_00027/1Medical Research Council Precision Medicine Doctoral Training ProgrammeNIAID NIH HHS R01 AI074345NIAID NIH HHS U01 AI099959NIAID NIH HHS UM1 AI068636NIGMS NIH HHS U01 GM110749NIH HHS GM110749NIH HHS R01 AI074345-06A1NIH HHS U01AI099959NIH HHS UM1AI068636NIMH NIH HHS P30 MH062246PEPFARWellcome TrustWellcome Trust 222329/Z/21/Z
6 · The paper itself
Abstract
The Sustainable East Africa Research in Community Health (SEARCH) trial was a universal test-and-treat (UTT) trial in rural Uganda and Kenya, aiming to lower regional HIV-1 incidence. Here, we quantify breakthrough HIV-1 transmissions occurring during the trial from population-based, dried blood spot samples. Between 2013 and 2017, we obtained 549
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Detection of HIV-1 Transmission Clusters from Dried Blood Spots within a Universal Test-and-Treat Trial in East Africa. · full record | OpenQuestion